C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/47 (2006.01) A61K 38/17 (2006.01)
Patent
CA 2544467
The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic.
L'invention concerne un peptide de bas poids moléculaire (ou une séquence de peptides apparentés) isolé des glandes salivaires sous-maxilaires de la musaraigne de l'espèce Blarina comme agent paralytique. Ce nouvel agent paralytique est utile comme bloquant neuromusculaire ou analgésique.
Steeves Bradley J.
Stewart John M.
Vernes Karl
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Soricimed Biopharma Inc.
Steeves Bradley J.
Stewart John M.
Vernes Karl
LandOfFree
Shrew paralytic peptide for use in neuromuscular therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Shrew paralytic peptide for use in neuromuscular therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Shrew paralytic peptide for use in neuromuscular therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1555710